Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

書誌詳細
主要な著者:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
フォーマット:	Conference item
出版事項:	2011

類似資料

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
著者:: Gillies, R, 等
出版事項: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
著者:: Gillies, R, 等
出版事項: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
著者:: Hatch, S, 等
出版事項: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
著者:: Graf, Nora, 等
出版事項: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
著者:: MacGregor, T, 等
出版事項: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
著者:: Hatch, S, 等
出版事項: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
著者:: T. P. MacGregor, 等
出版事項: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
著者:: Sharma, R, 等
出版事項: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
著者:: Gillies, R, 等
出版事項: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
著者:: Gillies, R, 等
出版事項: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
著者:: McHugh, PJ
出版事項: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
著者:: Peter J McHugh
出版事項: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
著者:: Mariangela Sabatella, 等
出版事項: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
著者:: Findlay, J, 等
出版事項: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
著者:: Yang, J, 等
出版事項: (2010)

Oesophageal and gastro-oesophageal junction tumours
著者:: Bird-Lieberman, E, 等
出版事項: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
著者:: Anwaar Ahmad, 等
出版事項: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
著者:: Findlay, J, 等
出版事項: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
著者:: den Boer, RB, 等
出版事項: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
著者:: Ming-Yii Huang, 等
出版事項: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
著者:: Abdullah, U
出版事項: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
著者:: Shibo Li, 等
出版事項: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
著者:: Millo, J, 等
出版事項: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
著者:: Kaina Bernd, 等
出版事項: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
著者:: Thomas, A, 等
出版事項: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
著者:: Sile Li, 等
出版事項: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
著者:: Bhagwat, N, 等
出版事項: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
著者:: Maryam Faridounnia, 等
出版事項: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
著者:: Jiajia Wang, 等
出版事項: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
著者:: Wang, A, 等
出版事項: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
著者:: Wang, A, 等
出版事項: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
著者:: A. G. M. T. Powell, 等
出版事項: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
著者:: Findlay, J, 等
出版事項: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
著者:: Jing Xue, 等
出版事項: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
著者:: Xin Zhang, 等
出版事項: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
著者:: Gillies, R, 等
出版事項: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
著者:: Rana, M, 等
出版事項: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
著者:: Matheus Treuk Medeiros de Araújo
出版事項: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
著者:: Mukherjee, S, 等
出版事項: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
著者:: Gillies, R, 等
出版事項: (2010)